Madrigal Pharmaceuticals (MDGL) Debt to Equity (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Debt to Equity of $0.63 for Q1 2026, up 277.12% year-over-year from $0.17 in Q1 2025, and up 11.05% quarter-over-quarter from $0.56 in Q4 2025.
Madrigal Pharmaceuticals (MDGL) Debt to Equity (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 12 years of Debt to Equity data on file, last reported at $0.63 in Q1 2026.
- Debt to Equity for Q1 2026 came in at $0.63, up 277.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.63 (up 277.12% YoY), and the FY2025 annual result was $0.56, up 261.85% from the prior year.
- Debt to Equity improved to $0.63 in Q1 2026 per MDGL's latest filing, from $0.56 in the prior quarter.
- Over five years, Debt to Equity peaked at $5.16 in Q3 2023 and troughed at $0.14 in Q2 2024.
- A 5-year average of $0.94 and a median of $0.41 in 2023 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2024 and 2026: Debt to Equity slumped 97.08% in 2024, then soared 277.12% in 2026.
- A 5-year view of Debt to Equity shows it stood at $0.25 in 2022, then increased by 14.1% to $0.28 in 2023, then sank by 45.3% to $0.16 in 2024, then soared by 261.85% to $0.56 in 2025, then grew by 11.05% to $0.63 in 2026.
- Business Quant data shows MDGL's Debt to Equity at $0.63 in Q1 2026, $0.56 in Q4 2025, and $0.54 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Madrigal Pharmaceuticals | 14.67 Bn | 14.44 Bn | - | 0.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.63 |
| Dec 31, 2025 | 0.56 |
| Sep 30, 2025 | 0.54 |
| Jun 30, 2025 | 0.17 |
| Mar 31, 2025 | 0.17 |
| Dec 31, 2024 | 0.16 |
| Sep 30, 2024 | 0.15 |
| Jun 30, 2024 | 0.14 |
| Mar 31, 2024 | 0.14 |
| Dec 31, 2023 | 0.28 |
| Sep 30, 2023 | 5.16 |
| Jun 30, 2023 | 0.96 |
| Mar 31, 2023 | 0.56 |
| Dec 31, 2022 | 0.25 |
| Sep 30, 2022 | 4.59 |
| Jun 30, 2022 | 0.58 |
| Jun 30, 2016 | 0.00 |
| Mar 31, 2016 | 0.05 |
| Dec 31, 2015 | -0.09 |
| Sep 30, 2015 | 0.11 |